Cyclic nucleotide analogs as carcinostatic agents.
D000227:Adenine Nucleotides / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents; D001089:Arabinose / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D002460:Cell Line; D004247:DNA / Q000096:biosynthesis*; D006801:Humans; D037102:Lectins / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000378:metabolism; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D009705:Nucleosides / Q000494:pharmacology; D009711:Nucleotides / Q000494:pharmacology* / Q000627:therapeutic use*; D011685:Purine Nucleotides / Q000494:pharmacology; D011687:Purines / Q000494:pharmacology; D013301:Streptolysins / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013440:Sulfides / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000227:Adenine Nucleotides; D000970:Antineoplastic Agents; D037102:Lectins; D009705:Nucleosides; D009711:Nucleotides; D011685:Purine Nucleotides; D011687:Purines; D013301:Streptolysins; D013438:Sulfhydryl Compounds; D013440:Sulfides; D014316:Tritium; D004247:DNA; D001089:Arabinose; D013936:Thymidine